<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link href="https://feeds.simplecast.com/VQFPgb5X" rel="self" title="MP3 Audio" type="application/atom+xml"/>
    <atom:link href="https://simplecast.superfeedr.com" rel="hub" xmlns="http://www.w3.org/2005/Atom"/>
    <generator>https://simplecast.com</generator>
    <title>Medscape InDiscussion: Psoriasis</title>
    <description>Listen to Medscape InDiscussion: Psoriasis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep1-2026a1000511). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</description>
    <copyright>Copyright 2026, Medscape</copyright>
    <language>en</language>
    <pubDate>Wed, 25 Mar 2026 13:58:25 +0000</pubDate>
    <lastBuildDate>Mon, 6 Apr 2026 15:40:50 +0000</lastBuildDate>
    <image>
      <link>https://www.medscape.com/indiscussion-psoriasis</link>
      <title>Medscape InDiscussion: Psoriasis</title>
      <url>https://image.simplecastcdn.com/images/46b6ff21-b36d-4371-9d19-5276b5a3b91e/f31fb441-c8d6-4696-a384-a65c446aee0c/3000x3000/id_psosiasis_show_image.jpg?aid=rss_feed</url>
    </image>
    <link>https://www.medscape.com/indiscussion-psoriasis</link>
    <itunes:type>episodic</itunes:type>
    <itunes:summary>Listen to Medscape InDiscussion: Psoriasis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep1-2026a1000511). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</itunes:summary>
    <itunes:author>Medscape</itunes:author>
    <itunes:explicit>false</itunes:explicit>
    <itunes:image href="https://image.simplecastcdn.com/images/46b6ff21-b36d-4371-9d19-5276b5a3b91e/f31fb441-c8d6-4696-a384-a65c446aee0c/3000x3000/id_psosiasis_show_image.jpg?aid=rss_feed"/>
    <itunes:new-feed-url>https://feeds.simplecast.com/VQFPgb5X</itunes:new-feed-url>
    <itunes:owner>
      <itunes:name>Medscape Podcasts</itunes:name>
      <itunes:email>medscapepodcasts@webmd.net</itunes:email>
    </itunes:owner>
    <itunes:category text="Science"/>
    <itunes:category text="Health &amp; Fitness">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <item>
      <guid isPermaLink="false">b75f497a-9df3-413e-9a3b-12ee88c9dd67</guid>
      <title>Next-Gen Oral Therapies Reshaping Psoriasis Care</title>
      <description><![CDATA[<p>Drs Steven Feldman and Tina Bhutani-Jacques explore how next-generation oral therapies are closing the gap with biologics and reshaping psoriasis care.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep2-2026a10006a5" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep2-2026a10006a5</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Acitretin Revisited in the Era of Biologics <a href="https://pubmed.ncbi.nlm.nih.gov/20673152/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/20673152/</a></p>
<p>Apremilast in Psoriasis: Current Landscape and Perspectives <a href="https://pubmed.ncbi.nlm.nih.gov/40739686/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/40739686/</a></p>
<p>Deucravacitinib Versus Placebo and Apremilast in Moderate-to-Severe Plaque Psoriasis: Efficacy and Safety Results From the 52-Week, Randomized, Double-Blinded, Placebo-Controlled Phase 3 POETYK PSO-1 Trial <a href="https://pubmed.ncbi.nlm.nih.gov/35820547/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35820547/</a></p>
<p>Apremilast Prescribing Information https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Otezla/otezla_pi_english.pdf</p>
<p>Deucravacitinib Prescribing Information https://packageinserts.bms.com/pi/pi_sotyktu.pdf</p>
<p>Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial <a href="https://pubmed.ncbi.nlm.nih.gov/39167366/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/39167366/</a></p>
<p>Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents <a href="https://pubmed.ncbi.nlm.nih.gov/38258121/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38258121/</a></p>
<p>Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents <a href="https://pubmed.ncbi.nlm.nih.gov/41191940/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/41191940/</a></p>
<p>National Psoriasis Foundation <a href="https://www.psoriasis.org/" rel="noopener noreferrer">https://www.psoriasis.org/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Wed, 25 Mar 2026 13:58:25 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Tina Bhutani-Jacques)</author>
      <link>https://www.medscape.com/indiscussion-psoriasis</link>
      <content:encoded><![CDATA[<p>Drs Steven Feldman and Tina Bhutani-Jacques explore how next-generation oral therapies are closing the gap with biologics and reshaping psoriasis care.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep2-2026a10006a5" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep2-2026a10006a5</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Acitretin Revisited in the Era of Biologics <a href="https://pubmed.ncbi.nlm.nih.gov/20673152/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/20673152/</a></p>
<p>Apremilast in Psoriasis: Current Landscape and Perspectives <a href="https://pubmed.ncbi.nlm.nih.gov/40739686/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/40739686/</a></p>
<p>Deucravacitinib Versus Placebo and Apremilast in Moderate-to-Severe Plaque Psoriasis: Efficacy and Safety Results From the 52-Week, Randomized, Double-Blinded, Placebo-Controlled Phase 3 POETYK PSO-1 Trial <a href="https://pubmed.ncbi.nlm.nih.gov/35820547/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35820547/</a></p>
<p>Apremilast Prescribing Information https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Otezla/otezla_pi_english.pdf</p>
<p>Deucravacitinib Prescribing Information https://packageinserts.bms.com/pi/pi_sotyktu.pdf</p>
<p>Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial <a href="https://pubmed.ncbi.nlm.nih.gov/39167366/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/39167366/</a></p>
<p>Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents <a href="https://pubmed.ncbi.nlm.nih.gov/38258121/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38258121/</a></p>
<p>Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents <a href="https://pubmed.ncbi.nlm.nih.gov/41191940/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/41191940/</a></p>
<p>National Psoriasis Foundation <a href="https://www.psoriasis.org/" rel="noopener noreferrer">https://www.psoriasis.org/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="20110917" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/fb026925-e777-4fb0-9e26-d1799bfb1936/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=fb026925-e777-4fb0-9e26-d1799bfb1936&amp;feed=VQFPgb5X"/>
      <itunes:title>Next-Gen Oral Therapies Reshaping Psoriasis Care</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Tina Bhutani-Jacques</itunes:author>
      <itunes:duration>00:20:56</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
      <itunes:season>4</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">1156790d-843b-4182-8136-8f31369ce817</guid>
      <title>Can Fixing Adherence Fix Psoriasis Outcomes?</title>
      <description><![CDATA[<p>Join Drs Steven Feldman and Bernard Vrijens as they discuss the theory and practice of improving treatment adherence for better patient outcomes in psoriasis.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep1-2026a10006a1" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep1-2026a10006a1</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.  </p>
<p><strong>Resources</strong></p>
<p>Psoriasis <a href="https://emedicine.medscape.com/article/1943419-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1943419-overview</a></p>
<p>The Importance of Assessing Drug Exposure and Medication Adherence in Evaluating Investigational Medications: Ensuring Validity and Reliability of Clinical Trial Results <a href="https://pubmed.ncbi.nlm.nih.gov/38135800/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38135800/</a></p>
<p>Comparing Compliance Patterns Between Randomized Treatments <a href="https://pubmed.ncbi.nlm.nih.gov/9204220/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/9204220/</a></p>
<p>A Scoping Review of Studies Comparing the Medication Event Monitoring System (MEMS) With Alternative Methods for Measuring Medication Adherence <a href="https://pubmed.ncbi.nlm.nih.gov/27005306/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/27005306/</a></p>
<p>A New Taxonomy for Describing and Defining Adherence to Medications <a href="https://pubmed.ncbi.nlm.nih.gov/22486599/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/22486599/</a></p>
<p>One in 3 Prescriptions Are Never Redeemed: Primary Nonadherence in an Outpatient Clinic <a href="https://pubmed.ncbi.nlm.nih.gov/18467003/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/18467003/</a></p>
<p>Data Resource Profile: The Danish National Prescription Registry <a href="https://pubmed.ncbi.nlm.nih.gov/27789670/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/27789670/</a></p>
<p>Tachyphylaxis to Topical Glucocorticoids; What Is the Evidence? <a href="https://pubmed.ncbi.nlm.nih.gov/24010503/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/24010503/</a></p>
<p>Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents <a href="https://pubmed.ncbi.nlm.nih.gov/38258121/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38258121/</a></p>
<p>10 Tips to Improve Adherence to Immunosuppressive Medication After Kidney Transplantation <a href="https://pubmed.ncbi.nlm.nih.gov/40521289/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/40521289/</a></p>
<p>The Health Buddies App as a Novel Tool to Improve Adherence and Knowledge in Atrial Fibrillation Patients: A Pilot Study <a href="https://pubmed.ncbi.nlm.nih.gov/28724512/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/28724512/</a></p>
<p>6MP Adherence in a Multiracial Cohort of Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study <a href="https://pubmed.ncbi.nlm.nih.gov/24829202/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/24829202/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Wed, 25 Mar 2026 13:51:10 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Bernard Vrijens)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep1-2026a10006a1</link>
      <content:encoded><![CDATA[<p>Join Drs Steven Feldman and Bernard Vrijens as they discuss the theory and practice of improving treatment adherence for better patient outcomes in psoriasis.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep1-2026a10006a1" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep1-2026a10006a1</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.  </p>
<p><strong>Resources</strong></p>
<p>Psoriasis <a href="https://emedicine.medscape.com/article/1943419-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1943419-overview</a></p>
<p>The Importance of Assessing Drug Exposure and Medication Adherence in Evaluating Investigational Medications: Ensuring Validity and Reliability of Clinical Trial Results <a href="https://pubmed.ncbi.nlm.nih.gov/38135800/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38135800/</a></p>
<p>Comparing Compliance Patterns Between Randomized Treatments <a href="https://pubmed.ncbi.nlm.nih.gov/9204220/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/9204220/</a></p>
<p>A Scoping Review of Studies Comparing the Medication Event Monitoring System (MEMS) With Alternative Methods for Measuring Medication Adherence <a href="https://pubmed.ncbi.nlm.nih.gov/27005306/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/27005306/</a></p>
<p>A New Taxonomy for Describing and Defining Adherence to Medications <a href="https://pubmed.ncbi.nlm.nih.gov/22486599/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/22486599/</a></p>
<p>One in 3 Prescriptions Are Never Redeemed: Primary Nonadherence in an Outpatient Clinic <a href="https://pubmed.ncbi.nlm.nih.gov/18467003/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/18467003/</a></p>
<p>Data Resource Profile: The Danish National Prescription Registry <a href="https://pubmed.ncbi.nlm.nih.gov/27789670/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/27789670/</a></p>
<p>Tachyphylaxis to Topical Glucocorticoids; What Is the Evidence? <a href="https://pubmed.ncbi.nlm.nih.gov/24010503/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/24010503/</a></p>
<p>Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents <a href="https://pubmed.ncbi.nlm.nih.gov/38258121/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38258121/</a></p>
<p>10 Tips to Improve Adherence to Immunosuppressive Medication After Kidney Transplantation <a href="https://pubmed.ncbi.nlm.nih.gov/40521289/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/40521289/</a></p>
<p>The Health Buddies App as a Novel Tool to Improve Adherence and Knowledge in Atrial Fibrillation Patients: A Pilot Study <a href="https://pubmed.ncbi.nlm.nih.gov/28724512/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/28724512/</a></p>
<p>6MP Adherence in a Multiracial Cohort of Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study <a href="https://pubmed.ncbi.nlm.nih.gov/24829202/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/24829202/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="25895169" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/5c8ce514-f715-4115-b30a-17b86690224b/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=5c8ce514-f715-4115-b30a-17b86690224b&amp;feed=VQFPgb5X"/>
      <itunes:title>Can Fixing Adherence Fix Psoriasis Outcomes?</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Bernard Vrijens</itunes:author>
      <itunes:duration>00:26:58</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
      <itunes:season>4</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">7a85d3c7-8d99-446e-ae63-9ecd0cf258b0</guid>
      <title>Creams, Foams, and New Formulations: Rethinking Topical Therapy for Psoriasis</title>
      <description><![CDATA[<p>From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction. Join Drs Feldman and Armstrong as they discuss.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep6-2026a100069z. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Psoriasis <a href="https://emedicine.medscape.com/article/1943419-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1943419-overview</a></p>
<p>expertscape <a href="https://expertscape.com/" rel="noopener noreferrer">https://expertscape.com/</a></p>
<p>PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact <a href="https://pubmed.ncbi.nlm.nih.gov/40465498/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/40465498/</a></p>
<p>Topical Corticosteroids <a href="https://www.ncbi.nlm.nih.gov/books/NBK532940/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/books/NBK532940/</a></p>
<p>Psoriasis Clinical Guideline <a href="https://www.aad.org/member/clinical-quality/guidelines/psoriasis" rel="noopener noreferrer">https://www.aad.org/member/clinical-quality/guidelines/psoriasis</a></p>
<p>Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies <a href="https://pubmed.ncbi.nlm.nih.gov/23425140/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/23425140/</a></p>
<p>Keratosis Pilaris <a href="https://emedicine.medscape.com/article/1070651-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1070651-overview</a></p>
<p>Review of the Mechanism of Action of Coal Tar in Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/28814117/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/28814117/</a></p>
<p>Treatment Adherence Intervention Studies in Dermatology and Guidance on How to Support Adherence <a href="https://pubmed.ncbi.nlm.nih.gov/28188596/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/28188596/</a></p>
<p>Polyaphron Dispersion Technology, a Novel Topical Formulation and Delivery System Combining Drug Penetration, Local Tolerability and Convenience of Application <a href="https://pubmed.ncbi.nlm.nih.gov/36050567/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/36050567/</a></p>
<p>Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits <a href="https://pubmed.ncbi.nlm.nih.gov/34106439/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/34106439/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Wed, 16 Jul 2025 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr April W. Armstrong)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep6-2026a100069z</link>
      <content:encoded><![CDATA[<p>From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction. Join Drs Feldman and Armstrong as they discuss.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep6-2026a100069z. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Psoriasis <a href="https://emedicine.medscape.com/article/1943419-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1943419-overview</a></p>
<p>expertscape <a href="https://expertscape.com/" rel="noopener noreferrer">https://expertscape.com/</a></p>
<p>PDE4 Inhibitors: Bridging Molecular Insights With Clinical Impact <a href="https://pubmed.ncbi.nlm.nih.gov/40465498/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/40465498/</a></p>
<p>Topical Corticosteroids <a href="https://www.ncbi.nlm.nih.gov/books/NBK532940/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/books/NBK532940/</a></p>
<p>Psoriasis Clinical Guideline <a href="https://www.aad.org/member/clinical-quality/guidelines/psoriasis" rel="noopener noreferrer">https://www.aad.org/member/clinical-quality/guidelines/psoriasis</a></p>
<p>Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies <a href="https://pubmed.ncbi.nlm.nih.gov/23425140/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/23425140/</a></p>
<p>Keratosis Pilaris <a href="https://emedicine.medscape.com/article/1070651-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1070651-overview</a></p>
<p>Review of the Mechanism of Action of Coal Tar in Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/28814117/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/28814117/</a></p>
<p>Treatment Adherence Intervention Studies in Dermatology and Guidance on How to Support Adherence <a href="https://pubmed.ncbi.nlm.nih.gov/28188596/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/28188596/</a></p>
<p>Polyaphron Dispersion Technology, a Novel Topical Formulation and Delivery System Combining Drug Penetration, Local Tolerability and Convenience of Application <a href="https://pubmed.ncbi.nlm.nih.gov/36050567/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/36050567/</a></p>
<p>Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits <a href="https://pubmed.ncbi.nlm.nih.gov/34106439/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/34106439/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="20125505" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/f5b540e8-898e-4e2a-875c-7fdf1f2d2e87/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=f5b540e8-898e-4e2a-875c-7fdf1f2d2e87&amp;feed=VQFPgb5X"/>
      <itunes:title>Creams, Foams, and New Formulations: Rethinking Topical Therapy for Psoriasis</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr April W. Armstrong</itunes:author>
      <itunes:duration>00:20:53</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>6</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">835ec516-968f-4d41-823d-063b7a1a5eba</guid>
      <title>Smartphones and the Future of Psoriasis Care</title>
      <description><![CDATA[<p>Join Drs Steve Feldman and Alexis Ogdie as they explore digital tools that detect and monitor psoriasis and psoriatic arthritis — using only a smartphone, movement, and a few taps.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep5-2026a100069y" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep5-2026a100069y</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study <a href="https://pubmed.ncbi.nlm.nih.gov/38879192/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38879192/</a></p>
<p>Psorcast <a href="https://apps.apple.com/us/app/psorcast/id1473504102" rel="noopener noreferrer">https://apps.apple.com/us/app/psorcast/id1473504102</a></p>
<p>Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings <a href="https://pubmed.ncbi.nlm.nih.gov/39301469/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/39301469/</a></p>
<p>Sleep Problems in Patients With Psoriatic Arthritis: A Systematic Literature Review and Metaanalysis <a href="https://pubmed.ncbi.nlm.nih.gov/37127321/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/37127321/</a></p>
<p>The Impact of Dietary Interventions in Psoriatic Arthritis <a href="https://pubmed.ncbi.nlm.nih.gov/37339523/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/37339523/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Tue, 17 Jun 2025 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Alexis Ogdie)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep5-2026a100069y</link>
      <content:encoded><![CDATA[<p>Join Drs Steve Feldman and Alexis Ogdie as they explore digital tools that detect and monitor psoriasis and psoriatic arthritis — using only a smartphone, movement, and a few taps.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep5-2026a100069y" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep5-2026a100069y</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study <a href="https://pubmed.ncbi.nlm.nih.gov/38879192/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38879192/</a></p>
<p>Psorcast <a href="https://apps.apple.com/us/app/psorcast/id1473504102" rel="noopener noreferrer">https://apps.apple.com/us/app/psorcast/id1473504102</a></p>
<p>Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings <a href="https://pubmed.ncbi.nlm.nih.gov/39301469/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/39301469/</a></p>
<p>Sleep Problems in Patients With Psoriatic Arthritis: A Systematic Literature Review and Metaanalysis <a href="https://pubmed.ncbi.nlm.nih.gov/37127321/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/37127321/</a></p>
<p>The Impact of Dietary Interventions in Psoriatic Arthritis <a href="https://pubmed.ncbi.nlm.nih.gov/37339523/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/37339523/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="20948556" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/8d343d99-8e0f-4593-9094-fe70b46e323a/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=8d343d99-8e0f-4593-9094-fe70b46e323a&amp;feed=VQFPgb5X"/>
      <itunes:title>Smartphones and the Future of Psoriasis Care</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Alexis Ogdie</itunes:author>
      <itunes:duration>00:21:47</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>5</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">e11c4e60-fd62-46e6-bf5a-c68f2de5ef81</guid>
      <title>What&apos;s New in Psoriasis? Dermasphere Podcasters Weigh In</title>
      <description><![CDATA[<p>Dr Feldman is joined by Drs Luke Johnson and Michelle Tarbox of the popular podcast <i>Dermasphere</i>, to discuss trends and hot topics in psoriasis.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep4-2026a100069r" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep4-2026a100069r</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p><i>Dermasphere</i> - The Derm Podcast <a href="https://dermaspherepodcast.com/" rel="noopener noreferrer">https://dermaspherepodcast.com/</a></p>
<p><i>Skincast</i> <a href="https://healthcare.utah.edu/dermatology/skincast" rel="noopener noreferrer">https://healthcare.utah.edu/dermatology/skincast</a></p>
<p>Bimekizumab in Patients With Psoriatic Arthritis, Naive to Biologic Treatment: A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial (BE OPTIMAL) <a href="https://pubmed.ncbi.nlm.nih.gov/36493791/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/36493791/</a></p>
<p>Inflammatory Bowel Disease Induced by Bimekizumab <a href="https://pubmed.ncbi.nlm.nih.gov/35664026/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35664026/</a></p>
<p>Short-Term Exposure to a Western Diet Induces Psoriasiform Dermatitis by Promoting Accumulation of IL-17A-Producing γδ T Cells <a href="https://pubmed.ncbi.nlm.nih.gov/32057839/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/32057839/</a></p>
<p>Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives <a href="https://pubmed.ncbi.nlm.nih.gov/35769285/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35769285/</a></p>
<p>The Patient's Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy <a href="https://pubmed.ncbi.nlm.nih.gov/27474032/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/27474032/</a></p>
<p>Deucravacitinib Versus Placebo and Apremilast in Moderate to Severe Plaque Psoriasis: Efficacy and Safety Results From the 52-Week, Randomized, Double-Blinded, Placebo-Controlled Phase 3 POETYK PSO-1 Trial <a href="https://pubmed.ncbi.nlm.nih.gov/35820547/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35820547/</a></p>
<p>Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents <a href="https://pubmed.ncbi.nlm.nih.gov/38258121/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38258121/</a></p>
<p>Callus and Its Keratin Before and After Treatment With Acid Sodium Thioglycolate. A Study by Scanning and Conventional Electron Microscopy <a href="https://pubmed.ncbi.nlm.nih.gov/5132158/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/5132158/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Thu, 15 May 2025 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Luke Johnson, Dr Michelle Tarbox)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep4-2026a100069r</link>
      <content:encoded><![CDATA[<p>Dr Feldman is joined by Drs Luke Johnson and Michelle Tarbox of the popular podcast <i>Dermasphere</i>, to discuss trends and hot topics in psoriasis.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep4-2026a100069r" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep4-2026a100069r</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p><i>Dermasphere</i> - The Derm Podcast <a href="https://dermaspherepodcast.com/" rel="noopener noreferrer">https://dermaspherepodcast.com/</a></p>
<p><i>Skincast</i> <a href="https://healthcare.utah.edu/dermatology/skincast" rel="noopener noreferrer">https://healthcare.utah.edu/dermatology/skincast</a></p>
<p>Bimekizumab in Patients With Psoriatic Arthritis, Naive to Biologic Treatment: A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial (BE OPTIMAL) <a href="https://pubmed.ncbi.nlm.nih.gov/36493791/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/36493791/</a></p>
<p>Inflammatory Bowel Disease Induced by Bimekizumab <a href="https://pubmed.ncbi.nlm.nih.gov/35664026/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35664026/</a></p>
<p>Short-Term Exposure to a Western Diet Induces Psoriasiform Dermatitis by Promoting Accumulation of IL-17A-Producing γδ T Cells <a href="https://pubmed.ncbi.nlm.nih.gov/32057839/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/32057839/</a></p>
<p>Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives <a href="https://pubmed.ncbi.nlm.nih.gov/35769285/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35769285/</a></p>
<p>The Patient's Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy <a href="https://pubmed.ncbi.nlm.nih.gov/27474032/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/27474032/</a></p>
<p>Deucravacitinib Versus Placebo and Apremilast in Moderate to Severe Plaque Psoriasis: Efficacy and Safety Results From the 52-Week, Randomized, Double-Blinded, Placebo-Controlled Phase 3 POETYK PSO-1 Trial <a href="https://pubmed.ncbi.nlm.nih.gov/35820547/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35820547/</a></p>
<p>Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents <a href="https://pubmed.ncbi.nlm.nih.gov/38258121/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38258121/</a></p>
<p>Callus and Its Keratin Before and After Treatment With Acid Sodium Thioglycolate. A Study by Scanning and Conventional Electron Microscopy <a href="https://pubmed.ncbi.nlm.nih.gov/5132158/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/5132158/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="22793015" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/601249b5-be07-401c-9827-941614e3a586/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=601249b5-be07-401c-9827-941614e3a586&amp;feed=VQFPgb5X"/>
      <itunes:title>What&apos;s New in Psoriasis? Dermasphere Podcasters Weigh In</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Luke Johnson, Dr Michelle Tarbox</itunes:author>
      <itunes:duration>00:23:43</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>4</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">b60e5ee3-9815-4e36-b4ea-8aceaf70d938</guid>
      <title>Psoriasis and the Mind: A Two-Way Inflammatory Street</title>
      <description><![CDATA[<p> Join Drs Steven Feldman and John Koo as they discuss psychodermatology and the link between psoriasis, anxiety, depression, and other mental health conditions.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep3-2026a100069f" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep3-2026a100069f</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Psoriasis <a href="https://emedicine.medscape.com/article/1943419-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1943419-overview</a></p>
<p>Management of Psychodermatologic Disorders <a href="https://www.medscape.com/viewarticle/730033%5C_5" rel="noopener noreferrer">https://www.medscape.com/viewarticle/730033\_5</a></p>
<p>Association Between Psoriasis and Depression: A Traditional Review <a href="https://pubmed.ncbi.nlm.nih.gov/32944430/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/32944430/</a></p>
<p>The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials <a href="https://pubmed.ncbi.nlm.nih.gov/38616886/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38616886/</a></p>
<p>The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/23892536/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/23892536/</a></p>
<p>Biologic Treatments of Psoriasis: An Update for the Clinician <a href="https://pubmed.ncbi.nlm.nih.gov/33623366/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33623366/</a></p>
<p>Role of Janus Kinase Inhibitors in Therapy of Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/34640327/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/34640327/</a></p>
<p>Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis With Comorbid Conditions and Special Populations: A Review <a href="https://pubmed.ncbi.nlm.nih.gov/33861409/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33861409/</a></p>
<p>Depression and Suicidality in Psoriasis and Clinical Studies of Brodalumab: A Narrative Review <a href="https://pubmed.ncbi.nlm.nih.gov/31939925/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/31939925/</a></p>
<p>Use of the Patient Health Questionnaire (PHQ-9) in Practice: Interactions Between Patients and Physicians <a href="https://pubmed.ncbi.nlm.nih.gov/32564676/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/32564676/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Thu, 17 Apr 2025 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr John Koo)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep3-2026a100069f</link>
      <content:encoded><![CDATA[<p> Join Drs Steven Feldman and John Koo as they discuss psychodermatology and the link between psoriasis, anxiety, depression, and other mental health conditions.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep3-2026a100069f" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep3-2026a100069f</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Psoriasis <a href="https://emedicine.medscape.com/article/1943419-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1943419-overview</a></p>
<p>Management of Psychodermatologic Disorders <a href="https://www.medscape.com/viewarticle/730033%5C_5" rel="noopener noreferrer">https://www.medscape.com/viewarticle/730033\_5</a></p>
<p>Association Between Psoriasis and Depression: A Traditional Review <a href="https://pubmed.ncbi.nlm.nih.gov/32944430/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/32944430/</a></p>
<p>The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials <a href="https://pubmed.ncbi.nlm.nih.gov/38616886/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38616886/</a></p>
<p>The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/23892536/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/23892536/</a></p>
<p>Biologic Treatments of Psoriasis: An Update for the Clinician <a href="https://pubmed.ncbi.nlm.nih.gov/33623366/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33623366/</a></p>
<p>Role of Janus Kinase Inhibitors in Therapy of Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/34640327/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/34640327/</a></p>
<p>Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis With Comorbid Conditions and Special Populations: A Review <a href="https://pubmed.ncbi.nlm.nih.gov/33861409/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/33861409/</a></p>
<p>Depression and Suicidality in Psoriasis and Clinical Studies of Brodalumab: A Narrative Review <a href="https://pubmed.ncbi.nlm.nih.gov/31939925/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/31939925/</a></p>
<p>Use of the Patient Health Questionnaire (PHQ-9) in Practice: Interactions Between Patients and Physicians <a href="https://pubmed.ncbi.nlm.nih.gov/32564676/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/32564676/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="20848667" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/71f8c387-fa5b-4cdc-8f64-93ce4107ffe5/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=71f8c387-fa5b-4cdc-8f64-93ce4107ffe5&amp;feed=VQFPgb5X"/>
      <itunes:title>Psoriasis and the Mind: A Two-Way Inflammatory Street</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr John Koo</itunes:author>
      <itunes:duration>00:21:41</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">305520f7-3e74-41e2-9077-f3a07f3b785a</guid>
      <title>For Psoriasis, Should Dermatologists Treat Obesity?</title>
      <description><![CDATA[<p>Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep2-2026a100065l" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep2-2026a100065l</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Psoriasis <a href="https://emedicine.medscape.com/article/1943419-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1943419-overview</a></p>
<p>Medscape InDiscussion: Obesity <a href="https://www.medscape.com/viewarticle/982631" rel="noopener noreferrer">https://www.medscape.com/viewarticle/982631</a></p>
<p>Update on Obesity in Psoriasis Patients <a href="https://pubmed.ncbi.nlm.nih.gov/37895330/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/37895330/</a></p>
<p>Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023 <a href="https://www.cdc.gov/nchs/data/databriefs/db508.pdf" rel="noopener noreferrer">https://www.cdc.gov/nchs/data/databriefs/db508.pdf</a></p>
<p>Obesity-Related Complications, Healthcare Resource Use and Weight Loss Strategies in Six European Countries: The RESOURCE Survey <a href="https://pubmed.ncbi.nlm.nih.gov/37258646/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/37258646/</a></p>
<p>The Link Between Obesity and the Skin <a href="https://pubmed.ncbi.nlm.nih.gov/35369048/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35369048/</a></p>
<p>Acanthosis Nigricans <a href="https://emedicine.medscape.com/article/1102488-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1102488-overview</a></p>
<p>Medications for Obesity: A Review <a href="https://pubmed.ncbi.nlm.nih.gov/39037780/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/39037780/</a></p>
<p>The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials <a href="https://pubmed.ncbi.nlm.nih.gov/38616886/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38616886/</a></p>
<p>Role of the Gut-Brain Axis in Energy and Glucose Metabolism <a href="https://pubmed.ncbi.nlm.nih.gov/35474341/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35474341/</a></p>
<p>Hidradenitis Suppurativa <a href="https://emedicine.medscape.com/article/1073117-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1073117-overview</a></p>
<p>Biomarkers of Inflammation in Obesity-Psoriatic Patients <a href="https://pubmed.ncbi.nlm.nih.gov/31275060/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/31275060/</a></p>
<p>Robert Kushner, MD <a href="https://drrobertkushner.com/" rel="noopener noreferrer">https://drrobertkushner.com/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Tue, 18 Mar 2025 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Robert F. Kushner)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep2-2026a100065l</link>
      <content:encoded><![CDATA[<p>Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep2-2026a100065l" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep2-2026a100065l</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Psoriasis <a href="https://emedicine.medscape.com/article/1943419-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1943419-overview</a></p>
<p>Medscape InDiscussion: Obesity <a href="https://www.medscape.com/viewarticle/982631" rel="noopener noreferrer">https://www.medscape.com/viewarticle/982631</a></p>
<p>Update on Obesity in Psoriasis Patients <a href="https://pubmed.ncbi.nlm.nih.gov/37895330/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/37895330/</a></p>
<p>Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023 <a href="https://www.cdc.gov/nchs/data/databriefs/db508.pdf" rel="noopener noreferrer">https://www.cdc.gov/nchs/data/databriefs/db508.pdf</a></p>
<p>Obesity-Related Complications, Healthcare Resource Use and Weight Loss Strategies in Six European Countries: The RESOURCE Survey <a href="https://pubmed.ncbi.nlm.nih.gov/37258646/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/37258646/</a></p>
<p>The Link Between Obesity and the Skin <a href="https://pubmed.ncbi.nlm.nih.gov/35369048/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35369048/</a></p>
<p>Acanthosis Nigricans <a href="https://emedicine.medscape.com/article/1102488-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1102488-overview</a></p>
<p>Medications for Obesity: A Review <a href="https://pubmed.ncbi.nlm.nih.gov/39037780/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/39037780/</a></p>
<p>The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials <a href="https://pubmed.ncbi.nlm.nih.gov/38616886/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/38616886/</a></p>
<p>Role of the Gut-Brain Axis in Energy and Glucose Metabolism <a href="https://pubmed.ncbi.nlm.nih.gov/35474341/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35474341/</a></p>
<p>Hidradenitis Suppurativa <a href="https://emedicine.medscape.com/article/1073117-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/1073117-overview</a></p>
<p>Biomarkers of Inflammation in Obesity-Psoriatic Patients <a href="https://pubmed.ncbi.nlm.nih.gov/31275060/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/31275060/</a></p>
<p>Robert Kushner, MD <a href="https://drrobertkushner.com/" rel="noopener noreferrer">https://drrobertkushner.com/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="19283424" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/f3d9c381-3e0b-4d68-bb8c-e91870d4f7e9/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=f3d9c381-3e0b-4d68-bb8c-e91870d4f7e9&amp;feed=VQFPgb5X"/>
      <itunes:title>For Psoriasis, Should Dermatologists Treat Obesity?</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Robert F. Kushner</itunes:author>
      <itunes:duration>00:20:03</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">f94a4332-98c8-4f66-8173-5965dab31c46</guid>
      <title>Cost, Coverage, and Psoriasis: Overcoming Care Barriers</title>
      <description><![CDATA[<p>Join Drs Steven Feldman and Jules Lipoff as they discuss teledermatology, the cost of prescriptions, and other barriers to care people with psoriasis face.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep1-2026a100065h" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep1-2026a100065h</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>The Role of the Physician in Patient Perceptions of Barriers to Primary Adherence With Acne Medications <a href="https://pubmed.ncbi.nlm.nih.gov/29490358/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/29490358/</a></p>
<p>Ciclopirox Nail Lacquer Topical Solution 8% in the Treatment of Toenail Onychomycosis <a href="https://pubmed.ncbi.nlm.nih.gov/11051136/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11051136/</a></p>
<p>Efinaconazole in Onychomycosis <a href="https://pubmed.ncbi.nlm.nih.gov/34902110/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/34902110/</a></p>
<p>Cost Effectiveness of Oral Terbinafine (Lamisil) Compared With Oral Fluconazole (Diflucan) in the Treatment of Patients With Toenail Onychomycosis <a href="https://pubmed.ncbi.nlm.nih.gov/11994041/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11994041/</a></p>
<p>Prescription Cost-Saving Platforms in Dermatology <a href="https://pubmed.ncbi.nlm.nih.gov/39259524/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/39259524/</a></p>
<p>GoodRx <a href="https://www.goodrx.com" rel="noopener noreferrer">https://www.goodrx.com</a></p>
<p>Mark Cuban CostPlus Drug Company <a href="https://www.costplusdrugs.com/" rel="noopener noreferrer">https://www.costplusdrugs.com/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Tue, 18 Mar 2025 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Jules Lipoff)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep1-2026a100065h</link>
      <content:encoded><![CDATA[<p>Join Drs Steven Feldman and Jules Lipoff as they discuss teledermatology, the cost of prescriptions, and other barriers to care people with psoriasis face.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape <a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep1-2026a100065h" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s3-ep1-2026a100065h</a>. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>The Role of the Physician in Patient Perceptions of Barriers to Primary Adherence With Acne Medications <a href="https://pubmed.ncbi.nlm.nih.gov/29490358/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/29490358/</a></p>
<p>Ciclopirox Nail Lacquer Topical Solution 8% in the Treatment of Toenail Onychomycosis <a href="https://pubmed.ncbi.nlm.nih.gov/11051136/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11051136/</a></p>
<p>Efinaconazole in Onychomycosis <a href="https://pubmed.ncbi.nlm.nih.gov/34902110/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/34902110/</a></p>
<p>Cost Effectiveness of Oral Terbinafine (Lamisil) Compared With Oral Fluconazole (Diflucan) in the Treatment of Patients With Toenail Onychomycosis <a href="https://pubmed.ncbi.nlm.nih.gov/11994041/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/11994041/</a></p>
<p>Prescription Cost-Saving Platforms in Dermatology <a href="https://pubmed.ncbi.nlm.nih.gov/39259524/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/39259524/</a></p>
<p>GoodRx <a href="https://www.goodrx.com" rel="noopener noreferrer">https://www.goodrx.com</a></p>
<p>Mark Cuban CostPlus Drug Company <a href="https://www.costplusdrugs.com/" rel="noopener noreferrer">https://www.costplusdrugs.com/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="19685172" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/52bad800-1983-421c-b38d-9cd58b042f4b/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=52bad800-1983-421c-b38d-9cd58b042f4b&amp;feed=VQFPgb5X"/>
      <itunes:title>Cost, Coverage, and Psoriasis: Overcoming Care Barriers</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Jules Lipoff</itunes:author>
      <itunes:duration>00:20:28</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
      <itunes:season>3</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">21df193c-8719-4e05-8cd5-7469ec936104</guid>
      <title>Red Rash and Pustules All Over? Here&apos;s What to Know</title>
      <description><![CDATA[<p>Drs Steve Feldman and Megan Noe fill in the gaps about pustular psoriasis, a relatively rare but serious condition that can be tough to diagnose.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep6-2026a10005nc" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep6-2026a10005nc</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Palmoplantar Pustulosis: Current Understanding of Disease Definition and Pathomechanism <a href="https://pubmed.ncbi.nlm.nih.gov/32201085/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/32201085/</a></p>
<p>Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655659/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655659/</a></p>
<p>Pathophysiology of Generalized Pustular Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/36779688/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/36779688/</a></p>
<p>Trial of Spesolimab for Generalized Pustular Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/34936739/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/34936739/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Thu, 24 Aug 2023 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Megan H. Noe)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep6-2026a10005nc</link>
      <content:encoded><![CDATA[<p>Drs Steve Feldman and Megan Noe fill in the gaps about pustular psoriasis, a relatively rare but serious condition that can be tough to diagnose.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep6-2026a10005nc" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep6-2026a10005nc</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Palmoplantar Pustulosis: Current Understanding of Disease Definition and Pathomechanism <a href="https://pubmed.ncbi.nlm.nih.gov/32201085/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/32201085/</a></p>
<p>Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655659/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655659/</a></p>
<p>Pathophysiology of Generalized Pustular Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/36779688/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/36779688/</a></p>
<p>Trial of Spesolimab for Generalized Pustular Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/34936739/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/34936739/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="21089743" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/dee11da7-a013-49bb-a93e-f9d7390b3d78/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=dee11da7-a013-49bb-a93e-f9d7390b3d78&amp;feed=VQFPgb5X"/>
      <itunes:title>Red Rash and Pustules All Over? Here&apos;s What to Know</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Megan H. Noe</itunes:author>
      <itunes:duration>00:21:51</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>6</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">90cfbd9a-af59-410b-a0db-899857c3e0b6</guid>
      <title>Psoriasis Climate Heats Up: Biosimilar Tsunami</title>
      <description><![CDATA[<p>Drs Steve Feldman and Andrew Blauvelt have a fascinating chat about contrasts and similarities between biologics and biosimilars, covering pharmacoeconomic and legal differences between the US and Europe.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep5-2026a10005mx). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future <a href="https://pubmed.ncbi.nlm.nih.gov/29549597/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/29549597/</a></p>
<p>International Psoriasis Council <a href="https://psoriasiscouncil.org/" rel="noopener noreferrer">https://psoriasiscouncil.org/</a></p>
<p>Biosimilars for Psoriasis: Clinical Studies to Determine Similarity <a href="https://pubmed.ncbi.nlm.nih.gov/27639072/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/27639072/</a></p>
<p>Safety, Efficacy and Drug Survival of Biologics and Biosimilars for Moderate-to-severe Plaque Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/29094341/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/29094341/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Wed, 26 Jul 2023 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Andrew Blauvelt)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep5-2026a10005mx</link>
      <content:encoded><![CDATA[<p>Drs Steve Feldman and Andrew Blauvelt have a fascinating chat about contrasts and similarities between biologics and biosimilars, covering pharmacoeconomic and legal differences between the US and Europe.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep5-2026a10005mx). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future <a href="https://pubmed.ncbi.nlm.nih.gov/29549597/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/29549597/</a></p>
<p>International Psoriasis Council <a href="https://psoriasiscouncil.org/" rel="noopener noreferrer">https://psoriasiscouncil.org/</a></p>
<p>Biosimilars for Psoriasis: Clinical Studies to Determine Similarity <a href="https://pubmed.ncbi.nlm.nih.gov/27639072/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/27639072/</a></p>
<p>Safety, Efficacy and Drug Survival of Biologics and Biosimilars for Moderate-to-severe Plaque Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/29094341/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/29094341/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="23585415" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/98322c80-c590-46bc-9bb3-df20453c666e/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=98322c80-c590-46bc-9bb3-df20453c666e&amp;feed=VQFPgb5X"/>
      <itunes:title>Psoriasis Climate Heats Up: Biosimilar Tsunami</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Andrew Blauvelt</itunes:author>
      <itunes:duration>00:23:44</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>5</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">d85f73c2-502d-4a6e-93db-eff4f0f5819c</guid>
      <title>Oral Psoriasis Drugs: What Are NPs Prescribing?</title>
      <description><![CDATA[<p>Dr Steven R. Feldman and nurse practitioner Lakshi M. Aldredge discuss systemic therapy for psoriasis and how nurse practitioners and physician associates fill an important gap.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep4-2026a10005mf" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep4-2026a10005mf</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199465/?report=reader" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199465/?report=reader</a></p>
<p>Tumor Necrosis Factor Inhibitors <a href="https://www.ncbi.nlm.nih.gov/books/NBK482425/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/books/NBK482425/</a></p>
<p>Deucravacitinib for the Treatment of Psoriatic Disease <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372960/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372960/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Wed, 28 Jun 2023 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Lakshi M. Aldredge)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep4-2026a10005mf</link>
      <content:encoded><![CDATA[<p>Dr Steven R. Feldman and nurse practitioner Lakshi M. Aldredge discuss systemic therapy for psoriasis and how nurse practitioners and physician associates fill an important gap.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep4-2026a10005mf" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep4-2026a10005mf</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199465/?report=reader" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199465/?report=reader</a></p>
<p>Tumor Necrosis Factor Inhibitors <a href="https://www.ncbi.nlm.nih.gov/books/NBK482425/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/books/NBK482425/</a></p>
<p>Deucravacitinib for the Treatment of Psoriatic Disease <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372960/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372960/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="22823461" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/68abeb8e-7113-4fd6-bf94-74346048f432/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=68abeb8e-7113-4fd6-bf94-74346048f432&amp;feed=VQFPgb5X"/>
      <itunes:title>Oral Psoriasis Drugs: What Are NPs Prescribing?</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Lakshi M. Aldredge</itunes:author>
      <itunes:duration>00:22:36</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>4</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">3b50db8a-f581-4032-b8a3-343ae7eb1698</guid>
      <title>Surfacing Synergistic Solutions for Limited Psoriasis</title>
      <description><![CDATA[<p>Drs Steven R. Feldman and Kim A. Papp discuss the expanding universe of opportunities and advances for halting limited psoriasis.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep3-2026a10005m7" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep3-2026a10005m7</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Trial of Roflumilast Cream for Chronic Plaque Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/32668113/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/32668113/</a></p>
<p>Psoriasis in Special Localizations <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330687/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330687/</a></p>
<p>Vitamin D Analogs in the Treatment of Psoriasis: Where Are We Standing and Where Will We Be Going? <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219168/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219168/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Thu, 25 May 2023 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Kim A. Papp)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep3-2026a10005m7</link>
      <content:encoded><![CDATA[<p>Drs Steven R. Feldman and Kim A. Papp discuss the expanding universe of opportunities and advances for halting limited psoriasis.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep3-2026a10005m7" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep3-2026a10005m7</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Trial of Roflumilast Cream for Chronic Plaque Psoriasis <a href="https://pubmed.ncbi.nlm.nih.gov/32668113/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/32668113/</a></p>
<p>Psoriasis in Special Localizations <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330687/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330687/</a></p>
<p>Vitamin D Analogs in the Treatment of Psoriasis: Where Are We Standing and Where Will We Be Going? <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219168/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219168/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="19637446" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/5459a6f8-ebc8-43b8-8cbb-7beb2ceb70e8/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=5459a6f8-ebc8-43b8-8cbb-7beb2ceb70e8&amp;feed=VQFPgb5X"/>
      <itunes:title>Surfacing Synergistic Solutions for Limited Psoriasis</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Kim A. Papp</itunes:author>
      <itunes:duration>00:19:39</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">5314fb24-2c19-43b4-bbdf-40bfbb200f28</guid>
      <title>Psoriasis Advocacy: A Model for Every Chronic Disease?</title>
      <description><![CDATA[<p>Dr Steven Feldman and Leah Howard, National Psoriasis Foundation President and CEO, discuss how an unseen and unheard patient population has begun to step out and speak up — at the US Capitol and beyond.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep1-2026a10005h0" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep1-2026a10005h0</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>National Psoriasis Foundation (NPF) <a href="https://www.psoriasis.org/" rel="noopener noreferrer">https://www.psoriasis.org/</a></p>
<p>Management of Psoriasis as a Systemic Disease: What Is the Evidence? <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187293/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187293/</a></p>
<p>Psoriasis: Classical and Emerging Comorbidities <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323693/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323693/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Tue, 25 Apr 2023 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Leah M. Howard)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep1-2026a10005h0</link>
      <content:encoded><![CDATA[<p>Dr Steven Feldman and Leah Howard, National Psoriasis Foundation President and CEO, discuss how an unseen and unheard patient population has begun to step out and speak up — at the US Capitol and beyond.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep1-2026a10005h0" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep1-2026a10005h0</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>National Psoriasis Foundation (NPF) <a href="https://www.psoriasis.org/" rel="noopener noreferrer">https://www.psoriasis.org/</a></p>
<p>Management of Psoriasis as a Systemic Disease: What Is the Evidence? <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187293/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187293/</a></p>
<p>Psoriasis: Classical and Emerging Comorbidities <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323693/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323693/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="21674733" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/f9abbed5-9078-4211-b81a-2e1317d08105/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=f9abbed5-9078-4211-b81a-2e1317d08105&amp;feed=VQFPgb5X"/>
      <itunes:title>Psoriasis Advocacy: A Model for Every Chronic Disease?</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Leah M. Howard</itunes:author>
      <itunes:duration>00:22:33</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">0e6fb5f4-a869-4cdd-baa2-e9a9f0db25ea</guid>
      <title>Can Psoriasis Care Limit CVD, PsA, and Depression?</title>
      <description><![CDATA[<p>Dr Steve Feldman speaks with Drs Mehta, Ritchlin, and Fried who share an exciting new roadmap for calming key psoriasis comorbidities.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep2-2026a10005h4" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep2-2026a10005h4</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-rich Necrotic Core: Results From a Prospective, Observational Study <a href="https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.120.011199" rel="noopener noreferrer">https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.120.011199</a></p>
<p>Treating the Skin With Biologics in Patients With Psoriasis Decreases the Incidence of Psoriatic Arthritis <a href="https://pubmed.ncbi.nlm.nih.gov/34281904/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/34281904/</a></p>
<p>The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener <a href="https://pubmed.ncbi.nlm.nih.gov/14583691/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/14583691/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Tue, 25 Apr 2023 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Nehal Mehta, Dr Christopher T. Ritchlin, Dr Richard Fried)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep2-2026a10005h4</link>
      <content:encoded><![CDATA[<p>Dr Steve Feldman speaks with Drs Mehta, Ritchlin, and Fried who share an exciting new roadmap for calming key psoriasis comorbidities.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep2-2026a10005h4" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s2-ep2-2026a10005h4</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-rich Necrotic Core: Results From a Prospective, Observational Study <a href="https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.120.011199" rel="noopener noreferrer">https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.120.011199</a></p>
<p>Treating the Skin With Biologics in Patients With Psoriasis Decreases the Incidence of Psoriatic Arthritis <a href="https://pubmed.ncbi.nlm.nih.gov/34281904/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/34281904/</a></p>
<p>The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener <a href="https://pubmed.ncbi.nlm.nih.gov/14583691/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/14583691/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="24949995" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/14a5ee50-a0de-40c1-a142-d95a44199a0b/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=14a5ee50-a0de-40c1-a142-d95a44199a0b&amp;feed=VQFPgb5X"/>
      <itunes:title>Can Psoriasis Care Limit CVD, PsA, and Depression?</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Nehal Mehta, Dr Christopher T. Ritchlin, Dr Richard Fried</itunes:author>
      <itunes:duration>00:25:53</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
      <itunes:season>2</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">7b2e7e58-6814-42d3-8eb7-8b1475911f89</guid>
      <title>Biologics in Psoriasis: A Spectacular Run</title>
      <description><![CDATA[<p>Host Dr Steven Feldman unpacks years of accrued knowledge on managing psoriasis using biologic therapy, with our special guest Dr Craig Leonardi.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep6-2026a10005g3). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Joint AAD-NPF Guidelines of Care for the Management and Treatment of Psoriasis With Biologics <a href="https://www.jaad.org/article/S0190-9622(18)33001-9/fulltext" rel="noopener noreferrer">https://www.jaad.org/article/S0190-9622(18)33001-9/fulltext</a></p>
<p>Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review <a href="https://pubmed.ncbi.nlm.nih.gov/32121574/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/32121574/</a></p>
<p>Biologic Treatments of Psoriasis: An Update for the Clinician <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896737/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896737/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Wed, 3 Aug 2022 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Craig Leonardi)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep6-2026a10005g3</link>
      <content:encoded><![CDATA[<p>Host Dr Steven Feldman unpacks years of accrued knowledge on managing psoriasis using biologic therapy, with our special guest Dr Craig Leonardi.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep6-2026a10005g3). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Joint AAD-NPF Guidelines of Care for the Management and Treatment of Psoriasis With Biologics <a href="https://www.jaad.org/article/S0190-9622(18)33001-9/fulltext" rel="noopener noreferrer">https://www.jaad.org/article/S0190-9622(18)33001-9/fulltext</a></p>
<p>Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review <a href="https://pubmed.ncbi.nlm.nih.gov/32121574/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/32121574/</a></p>
<p>Biologic Treatments of Psoriasis: An Update for the Clinician <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896737/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896737/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="16285531" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/b52d46be-a944-44c7-9962-8e14cf3ff5f0/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=b52d46be-a944-44c7-9962-8e14cf3ff5f0&amp;feed=VQFPgb5X"/>
      <itunes:title>Biologics in Psoriasis: A Spectacular Run</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Craig Leonardi</itunes:author>
      <itunes:duration>00:16:18</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>6</itunes:episode>
      <itunes:season>1</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">218297d1-0381-4764-b9cf-e2c9e64488de</guid>
      <title>Psoriasis Oral Agents: What to Know to Prescribe Like a Pro</title>
      <description><![CDATA[<p>This podcast has the goods on what oral therapy to recommend for almost any circumstance, even weddings. Drs Steven Feldman and Bruce Strober share a treasure trove of practical wisdom.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep5-2026a10005g0" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep5-2026a10005g0</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Acitretin Revisited in the Era of Biologics <a href="https://pubmed.ncbi.nlm.nih.gov/20673152/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/20673152/</a></p>
<p>Combining Biologic Therapies With Other Systemic Treatments in Psoriasis: Evidence-Based, Best-Practice Recommendations From the Medical Board of the National Psoriasis Foundation <a href="https://jamanetwork.com/journals/jamadermatology/article-abstract/2019961" rel="noopener noreferrer">https://jamanetwork.com/journals/jamadermatology/article-abstract/2019961</a></p>
<p>Joint American Academy of Dermatology–National Psoriasis Foundation Guidelines of Care for the Management of Psoriasis with Systemic Nonbiologic Therapies <a href="https://www.jaad.org/article/S0190-9622(20)30284-X/fulltext" rel="noopener noreferrer">https://www.jaad.org/article/S0190-9622(20)30284-X/fulltext</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Thu, 7 Jul 2022 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Bruce Strober)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep5-2026a10005g0</link>
      <content:encoded><![CDATA[<p>This podcast has the goods on what oral therapy to recommend for almost any circumstance, even weddings. Drs Steven Feldman and Bruce Strober share a treasure trove of practical wisdom.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep5-2026a10005g0" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep5-2026a10005g0</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Acitretin Revisited in the Era of Biologics <a href="https://pubmed.ncbi.nlm.nih.gov/20673152/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/20673152/</a></p>
<p>Combining Biologic Therapies With Other Systemic Treatments in Psoriasis: Evidence-Based, Best-Practice Recommendations From the Medical Board of the National Psoriasis Foundation <a href="https://jamanetwork.com/journals/jamadermatology/article-abstract/2019961" rel="noopener noreferrer">https://jamanetwork.com/journals/jamadermatology/article-abstract/2019961</a></p>
<p>Joint American Academy of Dermatology–National Psoriasis Foundation Guidelines of Care for the Management of Psoriasis with Systemic Nonbiologic Therapies <a href="https://www.jaad.org/article/S0190-9622(20)30284-X/fulltext" rel="noopener noreferrer">https://www.jaad.org/article/S0190-9622(20)30284-X/fulltext</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="22371123" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/386a5244-8312-4bb5-9669-f66e4a3604f4/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=386a5244-8312-4bb5-9669-f66e4a3604f4&amp;feed=VQFPgb5X"/>
      <itunes:title>Psoriasis Oral Agents: What to Know to Prescribe Like a Pro</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Bruce Strober</itunes:author>
      <itunes:duration>00:22:40</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>5</itunes:episode>
      <itunes:season>1</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">e3cea469-9407-4aa5-bc40-7a4dd06d00bd</guid>
      <title>When Should Phototherapy Be Used for Psoriasis?</title>
      <description><![CDATA[<p>Dr Joel Gelfand talks with host Dr Steven Feldman about why phototherapy is a great tool for treating psoriasis. He shares insights on who can benefit and how to approach patients about it.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape.com (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep4-2026a10005fr" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep4-2026a10005fr</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Plaque Psoriasis Treatment & Management <a href="https://emedicine.medscape.com/article/1108072-treatment#d11" rel="noopener noreferrer">https://emedicine.medscape.com/article/1108072-treatment#d11</a></p>
<p>Effect of UV-B Phototherapy on Plasma HIV Type 1 RNA Viral Level: A Self-Controlled Prospective Study <a href="https://jamanetwork.com/journals/jamadermatology/fullarticle/189280" rel="noopener noreferrer">https://jamanetwork.com/journals/jamadermatology/fullarticle/189280</a></p>
<p>Effect of Two Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991103/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991103/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Wed, 1 Jun 2022 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Joel M. Gelfand)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep4-2026a10005fr</link>
      <content:encoded><![CDATA[<p>Dr Joel Gelfand talks with host Dr Steven Feldman about why phototherapy is a great tool for treating psoriasis. He shares insights on who can benefit and how to approach patients about it.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape.com (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep4-2026a10005fr" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep4-2026a10005fr</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Plaque Psoriasis Treatment & Management <a href="https://emedicine.medscape.com/article/1108072-treatment#d11" rel="noopener noreferrer">https://emedicine.medscape.com/article/1108072-treatment#d11</a></p>
<p>Effect of UV-B Phototherapy on Plasma HIV Type 1 RNA Viral Level: A Self-Controlled Prospective Study <a href="https://jamanetwork.com/journals/jamadermatology/fullarticle/189280" rel="noopener noreferrer">https://jamanetwork.com/journals/jamadermatology/fullarticle/189280</a></p>
<p>Effect of Two Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991103/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991103/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="23833574" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/79795202-689f-40d4-be1d-d4428fbd59c0/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=79795202-689f-40d4-be1d-d4428fbd59c0&amp;feed=VQFPgb5X"/>
      <itunes:title>When Should Phototherapy Be Used for Psoriasis?</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Joel M. Gelfand</itunes:author>
      <itunes:duration>00:24:23</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>4</itunes:episode>
      <itunes:season>1</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">76985922-a6d5-48a2-8a9e-cdadead91786</guid>
      <title>Topical Prescribing Tips for Better Psoriasis Outcomes</title>
      <description><![CDATA[<p>Dermatologists Steven Feldman and Melinda Gooderham share expert advice and go-to options for topical use in patients with psoriasis.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape.com (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep3-2026a10005cb" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep3-2026a10005cb</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Joint AAD–NPF Guidelines of Care for the Management and Treatment of Psoriasis With Topical Therapy and Alternative Medicine Modalities for Psoriasis Severity Measures <a href="https://www.jaad.org/article/S0190-9622(20)32288-X/fulltext#secsectitle0050" rel="noopener noreferrer">https://www.jaad.org/article/S0190-9622(20)32288-X/fulltext#secsectitle0050</a></p>
<p>Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539972/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539972/</a></p>
<p>Optimizing the Use of Topical Agents in Psoriasis <a href="https://www.scmsjournal.com/wp-content/uploads/2017/02/v33i2s-Optimizing-the-use-of-Topical-Agents.pdf" rel="noopener noreferrer">https://www.scmsjournal.com/wp-content/uploads/2017/02/v33i2s-Optimizing-the-use-of-Topical-Agents.pdf</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Thu, 5 May 2022 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Melinda Gooderham)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep3-2026a10005cb</link>
      <content:encoded><![CDATA[<p>Dermatologists Steven Feldman and Melinda Gooderham share expert advice and go-to options for topical use in patients with psoriasis.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape.com (<a href="https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep3-2026a10005cb" rel="noopener noreferrer">https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep3-2026a10005cb</a>). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Joint AAD–NPF Guidelines of Care for the Management and Treatment of Psoriasis With Topical Therapy and Alternative Medicine Modalities for Psoriasis Severity Measures <a href="https://www.jaad.org/article/S0190-9622(20)32288-X/fulltext#secsectitle0050" rel="noopener noreferrer">https://www.jaad.org/article/S0190-9622(20)32288-X/fulltext#secsectitle0050</a></p>
<p>Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539972/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539972/</a></p>
<p>Optimizing the Use of Topical Agents in Psoriasis <a href="https://www.scmsjournal.com/wp-content/uploads/2017/02/v33i2s-Optimizing-the-use-of-Topical-Agents.pdf" rel="noopener noreferrer">https://www.scmsjournal.com/wp-content/uploads/2017/02/v33i2s-Optimizing-the-use-of-Topical-Agents.pdf</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="22300365" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/89cb1738-e4bc-48da-8099-ed38ab898f40/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=89cb1738-e4bc-48da-8099-ed38ab898f40&amp;feed=VQFPgb5X"/>
      <itunes:title>Topical Prescribing Tips for Better Psoriasis Outcomes</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Melinda Gooderham</itunes:author>
      <itunes:duration>00:22:58</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
      <itunes:season>1</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">823f1cb9-372e-4bc3-8a10-932e43e270ff</guid>
      <title>How to Quickly Spot and Manage Psoriasis Comorbidities</title>
      <description><![CDATA[<p>What's the best way to screen for common comorbidities in patients with psoriasis, and how do the experts respond when clues of systemic disease show up?</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep2-2026a1000560). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Psoriasis <a href="https://emedicine.medscape.com/article/1943419-overview#a6" rel="noopener noreferrer">https://emedicine.medscape.com/article/1943419-overview#a6</a></p>
<p>Axial Psoriatic Arthritis: An Update for Dermatologists <a href="https://www.jaad.org/article/S0190-9622(20)30959-2/fulltext" rel="noopener noreferrer">https://www.jaad.org/article/S0190-9622(20)30959-2/fulltext</a></p>
<p>Psoriatic Arthritis <a href="https://emedicine.medscape.com/article/2196539-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/2196539-overview</a></p>
<p>Psoriatic Arthritis: State of the Art Review <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297592/pdf/clinmed-17-1-65.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297592/pdf/clinmed-17-1-65.pdf</a></p>
<p>Joint American Academy of Dermatology–National Psoriasis Foundation Guidelines of Care for the Management of Psoriasis With Systemic Nonbiologic Therapies <a href="https://www.jaad.org/article/S0190-9622(20)30284-X/fulltext" rel="noopener noreferrer">https://www.jaad.org/article/S0190-9622(20)30284-X/fulltext</a></p>
<p>Axial Spondyloarthritis <a href="https://ard.bmj.com/content/80/12/1511.long" rel="noopener noreferrer">https://ard.bmj.com/content/80/12/1511.long</a></p>
<p>Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727454/pdf/40257%5C_2020%5C_Article%5C_578.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727454/pdf/40257\_2020\_Article\_578.pdf</a></p>
<p>Risankizumab, an IL-23 inhibitor, for Ankylosing Spondylitis: Results of a Randomized, Double-blind, Placebo-Controlled, Proof-of-concept, Dose-Finding Phase 2 Study <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104676/pdf/annrheumdis-2018-213328.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104676/pdf/annrheumdis-2018-213328.pdf</a></p>
<p>Axial Involvement in Psoriatic Arthritis Cohort (AXIS): The Protocol of a Joint Project of the Assessment of SpondyloArthritis International Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721378/pdf/10.1177%5C_1759720X211057975.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721378/pdf/10.1177\_1759720X211057975.pdf</a></p>
<p>Three Multicenter, Randomized, Double-blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis <a href="https://onlinelibrary.wiley.com/doi/10.1002/art.40728" rel="noopener noreferrer">https://onlinelibrary.wiley.com/doi/10.1002/art.40728</a></p>
<p>Efficacy of Guselkumab on Axial Involvement in Patients With Active Psoriatic Arthritis and Sacroiliitis: A Post-Hoc Analysis of the Phase 3 DISCOVER-1 and DISCOVER-2 Studies <a href="https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(21)00105-3/fulltext" rel="noopener noreferrer">https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(21)00105-3/fulltext</a></p>
<p>Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients With Peripheral Arthritis and Physician-Reported Spondylitis: Post-hoc Analyses From Two Phase III, Multicentre, Double-blind, Placebo-Controlled Studies (PSUMMIT-1/PSUMMIT-2) <a href="https://ard.bmj.com/content/75/11/1984.long" rel="noopener noreferrer">https://ard.bmj.com/content/75/11/1984.long</a></p>
<p>BASDAI Calculator <a href="https://qxmd.com/calculate/calculator%5C_299/basdai" rel="noopener noreferrer">https://qxmd.com/calculate/calculator\_299/basdai</a></p>
<p>Effectiveness, Costs and Cost-effectiveness of Chiropractic Care and Physiotherapy Compared With Information and Advice in the Treatment of Non-specific Chronic Low Back Pain: Study Protocol for a Randomised Controlled Trial <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741874/pdf/13063%5C_2017%5C_Article%5C_2351.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741874/pdf/13063\_2017\_Article\_2351.pdf</a></p>
<p>Axial Involvement in Psoriatic Arthritis: An Update for Rheumatologists <a href="https://www.sciencedirect.com/science/article/pii/S0049017221001190?via%3Dihub" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/S0049017221001190?via%3Dihub</a></p>
<p>Dactylitis: A Hallmark of Psoriatic Arthritis <a href="https://www.sciencedirect.com/science/article/pii/S0049017217306261?via%3Dihub" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/S0049017217306261?via%3Dihub</a></p>
<p>Psoriasis Workup <a href="https://emedicine.medscape.com/article/1943419-workup#c2" rel="noopener noreferrer">https://emedicine.medscape.com/article/1943419-workup#c2</a></p>
<p>Treatment Guidelines in Psoriatic Arthritis <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065461/pdf/kez383.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065461/pdf/kez383.pdf</a></p>
<p>Risk of Myocardial Infarction in Patients With Psoriasis <a href="https://jamanetwork.com/journals/jama/fullarticle/203598" rel="noopener noreferrer">https://jamanetwork.com/journals/jama/fullarticle/203598</a></p>
<p>Cardiovascular Disease Prevention for Psoriasis and Psoriatic Arthritis (CP3) <a href="https://www.med.upenn.edu/gelfand/research.html" rel="noopener noreferrer">https://www.med.upenn.edu/gelfand/research.html</a></p>
<p>Primary Care-Based Screening for Cardiovascular Risk Factors in Patients With Psoriasis <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113692/pdf/BJD-175-348.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113692/pdf/BJD-175-348.pdf</a></p>
<p>Psoriasis: Comorbidities <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252780/pdf/JDE-48-732.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252780/pdf/JDE-48-732.pdf</a></p>
<p>Changing Health Behaviours in Rheumatology: An Introduction to Behavioural Economics <a href="https://www.nature.com/articles/s41584-019-0336-1" rel="noopener noreferrer">https://www.nature.com/articles/s41584-019-0336-1</a></p>
<p>The Influence of Body Weight of Patients With Chronic Plaque Psoriasis on Biological Treatment Response <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262805/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262805/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Tue, 5 Apr 2022 05:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Alexis Ogdie-Beatty)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep2-2026a1000560</link>
      <content:encoded><![CDATA[<p>What's the best way to screen for common comorbidities in patients with psoriasis, and how do the experts respond when clues of systemic disease show up?</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep2-2026a1000560). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>Psoriasis <a href="https://emedicine.medscape.com/article/1943419-overview#a6" rel="noopener noreferrer">https://emedicine.medscape.com/article/1943419-overview#a6</a></p>
<p>Axial Psoriatic Arthritis: An Update for Dermatologists <a href="https://www.jaad.org/article/S0190-9622(20)30959-2/fulltext" rel="noopener noreferrer">https://www.jaad.org/article/S0190-9622(20)30959-2/fulltext</a></p>
<p>Psoriatic Arthritis <a href="https://emedicine.medscape.com/article/2196539-overview" rel="noopener noreferrer">https://emedicine.medscape.com/article/2196539-overview</a></p>
<p>Psoriatic Arthritis: State of the Art Review <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297592/pdf/clinmed-17-1-65.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297592/pdf/clinmed-17-1-65.pdf</a></p>
<p>Joint American Academy of Dermatology–National Psoriasis Foundation Guidelines of Care for the Management of Psoriasis With Systemic Nonbiologic Therapies <a href="https://www.jaad.org/article/S0190-9622(20)30284-X/fulltext" rel="noopener noreferrer">https://www.jaad.org/article/S0190-9622(20)30284-X/fulltext</a></p>
<p>Axial Spondyloarthritis <a href="https://ard.bmj.com/content/80/12/1511.long" rel="noopener noreferrer">https://ard.bmj.com/content/80/12/1511.long</a></p>
<p>Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727454/pdf/40257%5C_2020%5C_Article%5C_578.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727454/pdf/40257\_2020\_Article\_578.pdf</a></p>
<p>Risankizumab, an IL-23 inhibitor, for Ankylosing Spondylitis: Results of a Randomized, Double-blind, Placebo-Controlled, Proof-of-concept, Dose-Finding Phase 2 Study <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104676/pdf/annrheumdis-2018-213328.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104676/pdf/annrheumdis-2018-213328.pdf</a></p>
<p>Axial Involvement in Psoriatic Arthritis Cohort (AXIS): The Protocol of a Joint Project of the Assessment of SpondyloArthritis International Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721378/pdf/10.1177%5C_1759720X211057975.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721378/pdf/10.1177\_1759720X211057975.pdf</a></p>
<p>Three Multicenter, Randomized, Double-blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis <a href="https://onlinelibrary.wiley.com/doi/10.1002/art.40728" rel="noopener noreferrer">https://onlinelibrary.wiley.com/doi/10.1002/art.40728</a></p>
<p>Efficacy of Guselkumab on Axial Involvement in Patients With Active Psoriatic Arthritis and Sacroiliitis: A Post-Hoc Analysis of the Phase 3 DISCOVER-1 and DISCOVER-2 Studies <a href="https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(21)00105-3/fulltext" rel="noopener noreferrer">https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(21)00105-3/fulltext</a></p>
<p>Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients With Peripheral Arthritis and Physician-Reported Spondylitis: Post-hoc Analyses From Two Phase III, Multicentre, Double-blind, Placebo-Controlled Studies (PSUMMIT-1/PSUMMIT-2) <a href="https://ard.bmj.com/content/75/11/1984.long" rel="noopener noreferrer">https://ard.bmj.com/content/75/11/1984.long</a></p>
<p>BASDAI Calculator <a href="https://qxmd.com/calculate/calculator%5C_299/basdai" rel="noopener noreferrer">https://qxmd.com/calculate/calculator\_299/basdai</a></p>
<p>Effectiveness, Costs and Cost-effectiveness of Chiropractic Care and Physiotherapy Compared With Information and Advice in the Treatment of Non-specific Chronic Low Back Pain: Study Protocol for a Randomised Controlled Trial <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741874/pdf/13063%5C_2017%5C_Article%5C_2351.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741874/pdf/13063\_2017\_Article\_2351.pdf</a></p>
<p>Axial Involvement in Psoriatic Arthritis: An Update for Rheumatologists <a href="https://www.sciencedirect.com/science/article/pii/S0049017221001190?via%3Dihub" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/S0049017221001190?via%3Dihub</a></p>
<p>Dactylitis: A Hallmark of Psoriatic Arthritis <a href="https://www.sciencedirect.com/science/article/pii/S0049017217306261?via%3Dihub" rel="noopener noreferrer">https://www.sciencedirect.com/science/article/pii/S0049017217306261?via%3Dihub</a></p>
<p>Psoriasis Workup <a href="https://emedicine.medscape.com/article/1943419-workup#c2" rel="noopener noreferrer">https://emedicine.medscape.com/article/1943419-workup#c2</a></p>
<p>Treatment Guidelines in Psoriatic Arthritis <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065461/pdf/kez383.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065461/pdf/kez383.pdf</a></p>
<p>Risk of Myocardial Infarction in Patients With Psoriasis <a href="https://jamanetwork.com/journals/jama/fullarticle/203598" rel="noopener noreferrer">https://jamanetwork.com/journals/jama/fullarticle/203598</a></p>
<p>Cardiovascular Disease Prevention for Psoriasis and Psoriatic Arthritis (CP3) <a href="https://www.med.upenn.edu/gelfand/research.html" rel="noopener noreferrer">https://www.med.upenn.edu/gelfand/research.html</a></p>
<p>Primary Care-Based Screening for Cardiovascular Risk Factors in Patients With Psoriasis <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113692/pdf/BJD-175-348.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113692/pdf/BJD-175-348.pdf</a></p>
<p>Psoriasis: Comorbidities <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252780/pdf/JDE-48-732.pdf" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252780/pdf/JDE-48-732.pdf</a></p>
<p>Changing Health Behaviours in Rheumatology: An Introduction to Behavioural Economics <a href="https://www.nature.com/articles/s41584-019-0336-1" rel="noopener noreferrer">https://www.nature.com/articles/s41584-019-0336-1</a></p>
<p>The Influence of Body Weight of Patients With Chronic Plaque Psoriasis on Biological Treatment Response <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262805/" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262805/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="21884503" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/b779c541-f1cb-4e64-933c-539267a79dcd/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=b779c541-f1cb-4e64-933c-539267a79dcd&amp;feed=VQFPgb5X"/>
      <itunes:title>How to Quickly Spot and Manage Psoriasis Comorbidities</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Alexis Ogdie-Beatty</itunes:author>
      <itunes:duration>00:18:23</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
      <itunes:season>1</itunes:season>
    </item>
    <item>
      <guid isPermaLink="false">ec77ecc2-c922-4193-90af-b7e7c7678562</guid>
      <title>Sage Advice on Psoriasis and Quality-of-Life Assessment</title>
      <description><![CDATA[<p>What drives patients with psoriasis to seek care? Dr Steven Feldman and Professor Andrew Finlay, inventor of the Dermatology Life Quality Index, explore what matters most to patients.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep1-2026a1000511). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>How is the severity of psoriatic arthritis and psoriasis usually assessed? <a href="https://www.medscape.com/answers/2196539-155443/how-is-the-severity-of-psoriatic-arthritis-and-psoriasis-is-usually-assessed" rel="noopener noreferrer">https://www.medscape.com/answers/2196539-155443/how-is-the-severity-of-psoriatic-arthritis-and-psoriasis-is-usually-assessed</a></p>
<p>Dermatology Life Quality Index (DLQI) <a href="https://www.bad.org.uk/shared/get-file.ashx?id=1653&itemtype=document" rel="noopener noreferrer">https://www.bad.org.uk/shared/get-file.ashx?id=1653&itemtype=document</a></p>
<p>Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use <a href="https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1365-2230.1994.tb01167.x" rel="noopener noreferrer">https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1365-2230.1994.tb01167.x</a></p>
<p>Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatology Life Quality Index (DLQI): Further Data <a href="https://www.karger.com/Article/FullText/365390" rel="noopener noreferrer">https://www.karger.com/Article/FullText/365390</a></p>
<p>A Changed Life: The Life Experiences of Patients With Psoriasis Receiving Biological Treatment <a href="https://onlinelibrary.wiley.com/doi/10.1111/bjd.18876" rel="noopener noreferrer">https://onlinelibrary.wiley.com/doi/10.1111/bjd.18876</a></p>
<p>Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies <a href="https://pubmed.ncbi.nlm.nih.gov/23425140/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/23425140/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></description>
      <pubDate>Tue, 5 Apr 2022 04:00:00 +0000</pubDate>
      <author>medscapepodcasts@webmd.net (Dr Steven R. Feldman, Dr Andrew Finlay)</author>
      <link>https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep1-2026a1000511</link>
      <content:encoded><![CDATA[<p>What drives patients with psoriasis to seek care? Dr Steven Feldman and Professor Andrew Finlay, inventor of the Dermatology Life Quality Index, explore what matters most to patients.</p>
<p>Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep1-2026a1000511). The topics and discussions are planned, produced, and reviewed independently of our advertiser. This podcast is intended only for US healthcare professionals.</p>
<p><strong>Resources</strong></p>
<p>How is the severity of psoriatic arthritis and psoriasis usually assessed? <a href="https://www.medscape.com/answers/2196539-155443/how-is-the-severity-of-psoriatic-arthritis-and-psoriasis-is-usually-assessed" rel="noopener noreferrer">https://www.medscape.com/answers/2196539-155443/how-is-the-severity-of-psoriatic-arthritis-and-psoriasis-is-usually-assessed</a></p>
<p>Dermatology Life Quality Index (DLQI) <a href="https://www.bad.org.uk/shared/get-file.ashx?id=1653&itemtype=document" rel="noopener noreferrer">https://www.bad.org.uk/shared/get-file.ashx?id=1653&itemtype=document</a></p>
<p>Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use <a href="https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1365-2230.1994.tb01167.x" rel="noopener noreferrer">https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1365-2230.1994.tb01167.x</a></p>
<p>Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatology Life Quality Index (DLQI): Further Data <a href="https://www.karger.com/Article/FullText/365390" rel="noopener noreferrer">https://www.karger.com/Article/FullText/365390</a></p>
<p>A Changed Life: The Life Experiences of Patients With Psoriasis Receiving Biological Treatment <a href="https://onlinelibrary.wiley.com/doi/10.1111/bjd.18876" rel="noopener noreferrer">https://onlinelibrary.wiley.com/doi/10.1111/bjd.18876</a></p>
<p>Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies <a href="https://pubmed.ncbi.nlm.nih.gov/23425140/" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/23425140/</a></p><br/> <p>Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.</p>]]></content:encoded>
      <enclosure length="22254043" type="audio/mpeg" url="https://injector.simplecastaudio.com/edf424c4-7a29-4c69-b6c6-3eabf79ce912/episodes/bbf75170-cebb-4549-936e-f28abc70d91a/audio/128/default.mp3?aid=rss_feed&amp;awCollectionId=edf424c4-7a29-4c69-b6c6-3eabf79ce912&amp;awEpisodeId=bbf75170-cebb-4549-936e-f28abc70d91a&amp;feed=VQFPgb5X"/>
      <itunes:title>Sage Advice on Psoriasis and Quality-of-Life Assessment</itunes:title>
      <itunes:author>Dr Steven R. Feldman, Dr Andrew Finlay</itunes:author>
      <itunes:duration>00:22:47</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
      <itunes:season>1</itunes:season>
    </item>
  </channel>
</rss>